Correlation Between Cannara Biotech and GelStat Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and GelStat Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and GelStat Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannara Biotech and GelStat Corp, you can compare the effects of market volatilities on Cannara Biotech and GelStat Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of GelStat Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and GelStat Corp.

Diversification Opportunities for Cannara Biotech and GelStat Corp

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Cannara and GelStat is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and GelStat Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GelStat Corp and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with GelStat Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GelStat Corp has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and GelStat Corp go up and down completely randomly.

Pair Corralation between Cannara Biotech and GelStat Corp

Assuming the 90 days horizon Cannara Biotech is expected to under-perform the GelStat Corp. But the otc stock apears to be less risky and, when comparing its historical volatility, Cannara Biotech is 2.57 times less risky than GelStat Corp. The otc stock trades about 0.0 of its potential returns per unit of risk. The GelStat Corp is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  0.04  in GelStat Corp on September 1, 2024 and sell it today you would earn a total of  0.00  from holding GelStat Corp or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cannara Biotech  vs.  GelStat Corp

 Performance 
       Timeline  
Cannara Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cannara Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Cannara Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
GelStat Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in GelStat Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, GelStat Corp exhibited solid returns over the last few months and may actually be approaching a breakup point.

Cannara Biotech and GelStat Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cannara Biotech and GelStat Corp

The main advantage of trading using opposite Cannara Biotech and GelStat Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, GelStat Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GelStat Corp will offset losses from the drop in GelStat Corp's long position.
The idea behind Cannara Biotech and GelStat Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Valuation
Check real value of public entities based on technical and fundamental data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges